Sign in
4

Changes in Ownership

BRAINSTORM CELL THERAPEUTICS INC. Filed Acc 0001144204-18-047847

Chief Commercial Officer returned 2,805 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

Araya Arturo · Chief Commercial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2018-08-28 Returned to the company : show line 1 in the form −2,805 5,608 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2018-08-28 Grant or award : show line 2 in the form Stock Option (right to buy) +200,000 200,000 D
Loading xslF345X03/tv501988_4.xml…